| Oakdale Physical Therapy & Fitness | |
|
153 Oakdale Road, Suite 2, Johnson City, NY 13790 | |
| (607) 217-0827 | |
| (607) 217-0829 |
| Full Name | Oakdale Physical Therapy & Fitness |
|---|---|
| Type | Facility |
| Speciality | Physical Therapist |
| Location | 153 Oakdale Road, Johnson City, New York |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073554788 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Provider Name | Timothy C Gould |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1548244593 PECOS PAC ID: 7012933286 Enrollment ID: I20080129000137 |
News Archive
NexBio, Inc. announced today the publication in the Journal of Infectious Diseases of a preclinical study suggesting that treatment with DAS181 (Fludase®) may reduce the risk of secondary bacterial pneumonia following influenza virus infection.
Routine surveillance at small pig farms may be necessary, say researchers who identified both human and animal serum samples colonized with methicillin-resistant Staphylococcus aureus at such locations.
The federal government will begin tightening its rules to make sure that narrow networks don't get too narrow. There is some precedent for the reaction: In the 1990s, cheaper narrow-network H.M.O. plans proliferated in the employer market, but they disappeared after mass public outcry.
Merrion Pharmaceuticals Plc, a publicly listed product development company, today announced the signing of a Collaboration and Option agreement with Novo Nordisk. The agreement will evaluate the ability of Merrion's patented GIPET® technology to boost the oral bioavailability of an undisclosed proprietary compound.
› Verified 7 days ago
| Provider Name | John K Koniuto |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1598767121 PECOS PAC ID: 2365415783 Enrollment ID: I20111019000567 |
News Archive
NexBio, Inc. announced today the publication in the Journal of Infectious Diseases of a preclinical study suggesting that treatment with DAS181 (Fludase®) may reduce the risk of secondary bacterial pneumonia following influenza virus infection.
Routine surveillance at small pig farms may be necessary, say researchers who identified both human and animal serum samples colonized with methicillin-resistant Staphylococcus aureus at such locations.
The federal government will begin tightening its rules to make sure that narrow networks don't get too narrow. There is some precedent for the reaction: In the 1990s, cheaper narrow-network H.M.O. plans proliferated in the employer market, but they disappeared after mass public outcry.
Merrion Pharmaceuticals Plc, a publicly listed product development company, today announced the signing of a Collaboration and Option agreement with Novo Nordisk. The agreement will evaluate the ability of Merrion's patented GIPET® technology to boost the oral bioavailability of an undisclosed proprietary compound.
› Verified 7 days ago
| Provider Name | Kathryn Fazio |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1275966343 PECOS PAC ID: 2860621729 Enrollment ID: I20140219000380 |
News Archive
NexBio, Inc. announced today the publication in the Journal of Infectious Diseases of a preclinical study suggesting that treatment with DAS181 (Fludase®) may reduce the risk of secondary bacterial pneumonia following influenza virus infection.
Routine surveillance at small pig farms may be necessary, say researchers who identified both human and animal serum samples colonized with methicillin-resistant Staphylococcus aureus at such locations.
The federal government will begin tightening its rules to make sure that narrow networks don't get too narrow. There is some precedent for the reaction: In the 1990s, cheaper narrow-network H.M.O. plans proliferated in the employer market, but they disappeared after mass public outcry.
Merrion Pharmaceuticals Plc, a publicly listed product development company, today announced the signing of a Collaboration and Option agreement with Novo Nordisk. The agreement will evaluate the ability of Merrion's patented GIPET® technology to boost the oral bioavailability of an undisclosed proprietary compound.
› Verified 7 days ago
| Provider Name | Molly C Torbitt |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1760858625 PECOS PAC ID: 0941517411 Enrollment ID: I20150916000222 |
News Archive
NexBio, Inc. announced today the publication in the Journal of Infectious Diseases of a preclinical study suggesting that treatment with DAS181 (Fludase®) may reduce the risk of secondary bacterial pneumonia following influenza virus infection.
Routine surveillance at small pig farms may be necessary, say researchers who identified both human and animal serum samples colonized with methicillin-resistant Staphylococcus aureus at such locations.
The federal government will begin tightening its rules to make sure that narrow networks don't get too narrow. There is some precedent for the reaction: In the 1990s, cheaper narrow-network H.M.O. plans proliferated in the employer market, but they disappeared after mass public outcry.
Merrion Pharmaceuticals Plc, a publicly listed product development company, today announced the signing of a Collaboration and Option agreement with Novo Nordisk. The agreement will evaluate the ability of Merrion's patented GIPET® technology to boost the oral bioavailability of an undisclosed proprietary compound.
› Verified 7 days ago
| Provider Name | Alyssa Leigh Middaugh |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1407154024 PECOS PAC ID: 1153509120 Enrollment ID: I20170925000982 |
News Archive
NexBio, Inc. announced today the publication in the Journal of Infectious Diseases of a preclinical study suggesting that treatment with DAS181 (Fludase®) may reduce the risk of secondary bacterial pneumonia following influenza virus infection.
Routine surveillance at small pig farms may be necessary, say researchers who identified both human and animal serum samples colonized with methicillin-resistant Staphylococcus aureus at such locations.
The federal government will begin tightening its rules to make sure that narrow networks don't get too narrow. There is some precedent for the reaction: In the 1990s, cheaper narrow-network H.M.O. plans proliferated in the employer market, but they disappeared after mass public outcry.
Merrion Pharmaceuticals Plc, a publicly listed product development company, today announced the signing of a Collaboration and Option agreement with Novo Nordisk. The agreement will evaluate the ability of Merrion's patented GIPET® technology to boost the oral bioavailability of an undisclosed proprietary compound.
› Verified 7 days ago
| Provider Name | Christy M Tanton |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1609516632 PECOS PAC ID: 2860889904 Enrollment ID: I20220420001137 |
News Archive
NexBio, Inc. announced today the publication in the Journal of Infectious Diseases of a preclinical study suggesting that treatment with DAS181 (Fludase®) may reduce the risk of secondary bacterial pneumonia following influenza virus infection.
Routine surveillance at small pig farms may be necessary, say researchers who identified both human and animal serum samples colonized with methicillin-resistant Staphylococcus aureus at such locations.
The federal government will begin tightening its rules to make sure that narrow networks don't get too narrow. There is some precedent for the reaction: In the 1990s, cheaper narrow-network H.M.O. plans proliferated in the employer market, but they disappeared after mass public outcry.
Merrion Pharmaceuticals Plc, a publicly listed product development company, today announced the signing of a Collaboration and Option agreement with Novo Nordisk. The agreement will evaluate the ability of Merrion's patented GIPET® technology to boost the oral bioavailability of an undisclosed proprietary compound.
› Verified 7 days ago
| Provider Name | Beth Carey |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1902590896 PECOS PAC ID: 1759725336 Enrollment ID: I20240222001666 |
News Archive
NexBio, Inc. announced today the publication in the Journal of Infectious Diseases of a preclinical study suggesting that treatment with DAS181 (Fludase®) may reduce the risk of secondary bacterial pneumonia following influenza virus infection.
Routine surveillance at small pig farms may be necessary, say researchers who identified both human and animal serum samples colonized with methicillin-resistant Staphylococcus aureus at such locations.
The federal government will begin tightening its rules to make sure that narrow networks don't get too narrow. There is some precedent for the reaction: In the 1990s, cheaper narrow-network H.M.O. plans proliferated in the employer market, but they disappeared after mass public outcry.
Merrion Pharmaceuticals Plc, a publicly listed product development company, today announced the signing of a Collaboration and Option agreement with Novo Nordisk. The agreement will evaluate the ability of Merrion's patented GIPET® technology to boost the oral bioavailability of an undisclosed proprietary compound.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Oakdale Physical Therapy & Fitness 153 Oakdale Road, Suite 2, Johnson City, NY 13790 Ph: (607) 217-0827 | Oakdale Physical Therapy & Fitness 153 Oakdale Road, Suite 2, Johnson City, NY 13790 Ph: (607) 217-0827 |
News Archive
NexBio, Inc. announced today the publication in the Journal of Infectious Diseases of a preclinical study suggesting that treatment with DAS181 (Fludase®) may reduce the risk of secondary bacterial pneumonia following influenza virus infection.
Routine surveillance at small pig farms may be necessary, say researchers who identified both human and animal serum samples colonized with methicillin-resistant Staphylococcus aureus at such locations.
The federal government will begin tightening its rules to make sure that narrow networks don't get too narrow. There is some precedent for the reaction: In the 1990s, cheaper narrow-network H.M.O. plans proliferated in the employer market, but they disappeared after mass public outcry.
Merrion Pharmaceuticals Plc, a publicly listed product development company, today announced the signing of a Collaboration and Option agreement with Novo Nordisk. The agreement will evaluate the ability of Merrion's patented GIPET® technology to boost the oral bioavailability of an undisclosed proprietary compound.
› Verified 7 days ago
Mrs. Beth E Parks, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 257 Pollard Hill Rd, Johnson City, NY 13790 Phone: 607-760-1317 Fax: 607-862-3379 | |
Alesia Michelle Heimes, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 491 Reynolds Rd, Johnson City, NY 13790 Phone: 607-729-0044 | |
Ms. Colleen Frances Connors, D.P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 33 N Harrison St, Physical Therapy, Johnson City, NY 13790 Phone: 607-763-6033 | |
Dawn Salzman, P.T. Physical Therapist Medicare: Medicare Enrolled Practice Location: 18 Broad St, Johnson City, NY 13790 Phone: 607-798-7117 | |
Ms. Kathryn Sturek, DPT, MSPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 18 Broad St, Johnson City, NY 13790 Phone: 607-798-7117 | |
Tabitha Rae Toman, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 34 Harrison St, Johnson City, NY 13790 Phone: 607-763-2000 |